华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301267 华厦眼科

已收盘 11-10 15:00:00

{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":14.98,"timestamp":1794294201000,"preClose":15.04,"halted":0,"volume":4928498,"delay":0,"changeRate":-0.004,"floatShares":648000000,"shares":840000000,"eps":0.5633,"marketStatus":"已收盘","change":-0.06,"latestTime":"11-10 15:00:00","open":15.18,"high":15.19,"low":14.82,"amount":73617900,"amplitude":0.0246,"askPrice":14.99,"askSize":2,"bidPrice":14.98,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.5633,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794360600000},"marketStatusCode":5,"adr":0,"adjPreClose":15.04,"symbolType":"stock","openAndCloseTimeList":[[1794274200000,1794281400000],[1794286800000,1794294000000]],"highLimit":16.54,"lowLimit":13.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.26,"roa":"--","peRate":26.59329,"roe":"8.57%","epsLYR":0.53,"committee":0.335443,"marketValue":12583000000,"turnoverRate":0.0076,"status":1,"floatMarketCap":9714000000},"requestUrl":"/m/hq/s/301267/wiki","defaultTab":"wiki","newsList":[{"id":"2682390206","title":"华厦眼科：11月9日高管苏庆灿增持股份合计25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682390206","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682390206?lang=zh_cn&edition=full","pubTime":"2026-11-10 21:01","pubTimestamp":1794315693,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月10日市场公开信息、上市公司公告及交易所披露数据整理，华厦眼科最新董监高及相关人员股份变动情况：2026年11月9日公司高管,董事苏庆灿共增持公司股份25.0万股，占公司总股本为0.0298%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下：华厦眼科的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入14.66万，融资余额增加；融券净流出4900.0，融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000044828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681736610","title":"华厦眼科：11月4日高管苏庆灿增持股份合计2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681736610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681736610?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:01","pubTimestamp":1793883712,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月5日市场公开信息、上市公司公告及交易所披露数据整理，华厦眼科最新董监高及相关人员股份变动情况：2026年11月4日公司高管,董事苏庆灿共增持公司股份2.0万股，占公司总股本为0.0024%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下：华厦眼科的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入371.39万，融资余额增加；融券净流入2.24万，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500040810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680109030","title":"11月4日华厦眼科发生1笔大宗交易 成交金额2101.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680109030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680109030?lang=zh_cn&edition=full","pubTime":"2026-11-04 19:27","pubTimestamp":1793791652,"startTime":"0","endTime":"0","summary":"证券之星消息，11月4日华厦眼科发生大宗交易，交易数据如下：大宗交易成交价格14.01元，相对当日收盘价折价8.73%，成交150万股，成交金额2101.5万元，买方营业部为中国中金财富证券有限公司烟台黄海路证券营业部，卖方营业部为中国中金财富证券有限公司厦门分公司。近三个月该股共发生1笔大宗交易，合计成交1.5万手，折价成交1笔。截至2026年11月4日收盘，华厦眼科报收于15.35元，上涨0.79%，换手率1.15%，成交量7.45万手，成交额1.14亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400035587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678498140","title":"华厦眼科（301267）2026年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2678498140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678498140?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:43","pubTimestamp":1793191392,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华厦眼科发布2026年三季报。截至本报告期末，公司营业总收入33.41亿元，同比上升2.13%，归母净利润4.66亿元，同比上升7.49%。按单季度数据看，第三季度营业总收入11.56亿元，同比上升2.05%，第三季度归母净利润1.74亿元，同比上升14.83%。本报告期华厦眼科公司应收账款体量较大，当期应收账款占最新年报归母净利润比达75.4%。本文数据来源于华厦眼科2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800048092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678176595","title":"华厦眼科(301267)9月30日股东户数2.09万户，较上期增加4.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678176595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678176595?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:57","pubTimestamp":1793098627,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华厦眼科披露，截至2026年9月30日公司股东户数为2.09万户，较6月30日增加818.0户，增幅为4.06%。在医疗服务行业个股中，华厦眼科股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.74万户。从股价来看，2026年6月30日至2026年9月30日，华厦眼科区间涨幅为5.1%，在此期间股东户数增加818.0户，增幅为4.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678143979","title":"华厦眼科（301267）10月26日主力资金净买入41.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678143979","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678143979?lang=zh_cn&edition=full","pubTime":"2026-10-27 09:05","pubTimestamp":1793063121,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月26日收盘，华厦眼科报收于15.26元，上涨4.23%，换手率1.24%，成交量8.02万手，成交额1.21亿元。近5日资金流向一览见下表：华厦眼科融资融券信息显示，融资方面，当日融资买入702.2万元，融资偿还1118.75万元，融资净偿还416.56万元。华厦眼科主营业务：眼科医疗服务,向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务,同时还向社会大众提供眼疾、近视预防干预工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700011282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678919689","title":"三季度盈利提质 华厦眼科长期主义渐入兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2678919689","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678919689?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:58","pubTimestamp":1793019488,"startTime":"0","endTime":"0","summary":"今日，华厦眼科披露2026年三季度报告。今年前三季度，华厦眼科累计实现营业收入33.41亿元，同比增长2.13%；归母净利润4.66亿元，同比增长7.49%；整体净利率从去年同期的13.94%提升至14.77%。健康的现金流与利润增长相匹配，意味着华厦眼科并非依靠盲目扩张换取短期账面利润，而是通过提升经营质量，使本期盈利改善更具内生性与含金量。对华厦眼科而言，依托扎实的医疗底盘与持续优化的内部治理，使其长期主义路径正逐步落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261026/32408308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678195896","title":"华厦眼科：第四届董事会第五次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2678195896","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678195896?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:03","pubTimestamp":1793016180,"startTime":"0","endTime":"0","summary":"证券日报网讯 10月26日，华厦眼科发布公告称，公司于2026年10月26日召开第四届董事会第五次会议，审议通过《关于〈2026年第三季度报告〉的议案》《关于2026年中期利润分配方案的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-26/doc-iniwqhxp5281798.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-26/doc-iniwqhxp5281798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678164240","title":"华厦眼科最新公告：前三季度净利润同比增长7.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678164240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678164240?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:29","pubTimestamp":1793010575,"startTime":"0","endTime":"0","summary":"华厦眼科(301267.SZ)公告称，第三季度营业收入为11.56亿元，同比增长2.05%；归属于上市公司股东的净利润为1.74亿元，同比增长14.83%。前三季度营业收入为33.41亿元，同比增长2.13%；归属于上市公司股东的净利润为4.66亿元，同比增长7.49%。注：公司Q3净利润1.74亿，Q2净利润1.2亿，据此计算，Q3净利润环比增长44%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600026161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677457956","title":"华厦眼科（301267）披露持股5%以上股东权益变动至5%以下的提示性公告，10月22日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677457956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677457956?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:56","pubTimestamp":1792662989,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，华厦眼科报收于14.37元，较前一交易日下跌0.96%，最新总市值为120.71亿元。该股当日开盘14.51元，最高14.62元，最低14.37元，成交额达5879.25万元，换手率为0.63%。近日，华厦眼科医院集团股份有限公司披露《关于持股5%以上股东权益变动至5%以下的提示性公告》。本次权益变动后，涵蔚投资持有公司股份由45,731,250股减少至41,999,900股，持股比例由5.44420%降至4.99999%，不再为公司持股5%以上股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200031061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677967674","title":"10月21日华厦眼科发布公告，股东减持373.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677967674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677967674?lang=zh_cn&edition=full","pubTime":"2026-10-21 20:01","pubTimestamp":1792584090,"startTime":"0","endTime":"0","summary":"证券之星消息，10月21日华厦眼科发布公告《华厦眼科:简式权益变动报告书》，其股东厦门涵蔚股权投资合伙企业(有限合伙)于2026年9月21日至2026年10月21日间合计减持373.13万股，占公司目前总股本的0.4442%，变动期间该股股价下跌2.49%，截止10月21日收盘报14.51元。股东增减持详情见下表：根据华厦眼科2026年中报公布的十大股东详情如下：本文数据来源于华厦眼科公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100037439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675655147","title":"华厦眼科（301267）10月15日主力资金净卖出128.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675655147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675655147?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:08","pubTimestamp":1792112934,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，华厦眼科报收于14.81元，下跌0.34%，换手率0.56%，成交量3.62万手，成交额5346.03万元。近5日资金流向一览见下表：华厦眼科融资融券信息显示，融资方面，当日融资买入237.88万元，融资偿还294.52万元，融资净偿还56.64万元。华厦眼科主营业务：眼科医疗服务,向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务,同时还向社会大众提供眼疾、近视预防干预工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675478223","title":"华厦眼科：10月13日高管苏庆灿增持股份合计7.81万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675478223","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675478223?lang=zh_cn&edition=full","pubTime":"2026-10-14 21:01","pubTimestamp":1791982903,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月14日市场公开信息、上市公司公告及交易所披露数据整理，华厦眼科最新董监高及相关人员股份变动情况：2026年10月13日公司高管,董事苏庆灿共增持公司股份7.81万股，占公司总股本为0.0093%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下：华厦眼科的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出93.45万，融资余额减少；融券净流入1.49万，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400038053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675352495","title":"华厦眼科：10月12日高管苏庆灿增持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675352495","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675352495?lang=zh_cn&edition=full","pubTime":"2026-10-13 21:01","pubTimestamp":1791896485,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月13日市场公开信息、上市公司公告及交易所披露数据整理，华厦眼科最新董监高及相关人员股份变动情况：2026年10月12日公司高管,董事苏庆灿共增持公司股份10.0万股，占公司总股本为0.0119%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下：华厦眼科的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出236.27万，融资余额减少；融券净流入1.33万，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300037642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876132","title":"华厦眼科（301267）披露关于变更董事会秘书的公告，10月12日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876132","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876132?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:53","pubTimestamp":1791798783,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，华厦眼科报收于15.12元，较前一交易日下跌0.26%，最新总市值为127.01亿元。该股当日开盘15.16元，最高15.23元，最低15.01元，成交额达3188.73万元，换手率为0.33%。近日，华厦眼科医院集团股份有限公司发布《关于变更董事会秘书的公告》。公告显示，公司于2026年10月9日召开第四届董事会第四次会议，审议通过聘任杨未来女士为公司董事会秘书，任期至第四届董事会任期届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200024417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674846935","title":"股市必读：华厦眼科新发布《第四届董事会第四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674846935","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674846935?lang=zh_cn&edition=full","pubTime":"2026-10-12 03:43","pubTimestamp":1791747791,"startTime":"0","endTime":"0","summary":"公司公告汇总第四届董事会第四次会议决议公告华厦眼科医院集团股份有限公司于2026年10月9日召开第四届董事会第四次会议，审议通过《关于聘任董事会秘书的议案》；聘任杨未来女士为公司董事会秘书，任期至第四届董事会任期届满；会议由李晓峰主持，7名董事全部出席，表决结果为同意7票，反对0票，弃权0票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671121245","title":"华厦眼科：9月28日高管苏庆灿增持股份合计2.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671121245","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671121245?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:01","pubTimestamp":1790686884,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月29日市场公开信息、上市公司公告及交易所披露数据整理，华厦眼科最新董监高及相关人员股份变动情况：2026年9月28日公司高管,董事苏庆灿共增持公司股份2.7万股，占公司总股本为0.0032%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下：华厦眼科的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出344.36万，融资余额减少；融券净流出1.69万，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900037848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670484409","title":"股市必读：华厦眼科（301267）9月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2670484409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670484409?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:59","pubTimestamp":1790531949,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，华厦眼科报收于14.91元，下跌1.32%，换手率0.46%，成交量2.96万手，成交额4441.5万元。机构调研要点：截至2026年6月30日，公司已在全国19个省及直辖市运营64家眼科专科医院和55家视光中心。机构调研要点：公司2025年中期及年度分红合计2.16亿元，现金分红比例达49.12%；已披露《未来三年股东分红回报规划》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670416007","title":"【机构调研记录】安信基金调研华厦眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2670416007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670416007?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:01","pubTimestamp":1790294500,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月24日披露的机构调研信息，安信基金近期对1家上市公司进行了调研，相关名单如下：1）华厦眼科 调研纪要：目前，公司屈光手术高端术式占比超过50%，今年屈光业务整体呈量价齐升的良好趋势。截至2026年6月30日，公司已开设64家眼科专科医院和55家视光中心，将持续推进全国布局。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500004813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669617083","title":"顶级专家余克明加盟 华厦眼科加码屈光“人才战”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669617083","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669617083?lang=zh_cn&edition=full","pubTime":"2026-09-23 13:42","pubTimestamp":1790142122,"startTime":"0","endTime":"0","summary":"中国网财经9月23日讯 近日，原中山眼科中心近视眼激光治疗科主任余克明教授正式加盟华厦眼科医院集团，担任华厦眼科医院集团大湾区名誉院长、深圳南山华厦眼科医院首席专家、广州华厦维尔视眼科首席专家，同时受聘为华厦眼科医院集团学术委员会眼屈光学组主任委员。公开信息显示，余克明已受聘为华厦眼科医院集团学术委员会眼屈光学组主任委员，并入选“中国眼科医师明日之星计划”屈光手术技术规范化培训组指导专家。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/23/20260923973015.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/23/20260923973015.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260923/32378733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794330354406,"stockEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0894},{"period":"6month","weight":-0.1387},{"period":"1year","weight":-0.245},{"period":"ytd","weight":-0.1574}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":-0.0393},{"period":"3month","weight":-0.0717},{"period":"6month","weight":-0.1231},{"period":"1year","weight":-0.0883},{"period":"ytd","weight":-0.0769}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"20947人(较上一季度增加4.06%)","perCapita":"30956股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":"　　华厦眼科医院集团股份有限公司的主营业务是眼科医疗服务。公司的主要产品是白内障专科、屈光专科、眼底病专科、斜弱视与小儿眼科专科、眼表病专科、青光眼专科、眼眶与眼肿瘤专科、眼外伤专科、眼视光。公司下属医院厦门眼科中心是国家三级甲等专科医院、国家临床重点专科（眼科）建设单位，并设有博士后科研工作站和院士专家工作站。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}